Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention.
Krishnamurthy A, Keeble C, Anderson M, Somers K, Burton-Wood N, Harland C, Baxter P, McLenachan J, Blaxill J, Blackman DJ, Malkin C, Wheatcroft S, Greenwood J. Krishnamurthy A, et al. Among authors: mclenachan j. Open Heart. 2019 Jun 29;6(1):e000951. doi: 10.1136/openhrt-2018-000951. eCollection 2019. Open Heart. 2019. PMID: 31328001 Free PMC article.
Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population.
Shelton R, Eftychiou C, Somers K, Liu A, Burton-Wood N, Anderson M, Makri L, Blaxill J, McLenachan J, Wheatcroft S, Greenwood J, Blackman D. Shelton R, et al. Among authors: mclenachan j. EuroIntervention. 2013 May 20;9(1):118-24. doi: 10.4244/EIJV9I1A17. EuroIntervention. 2013. PMID: 23410540 Free article.
Real-world outcome from ST elevation myocardial infarction in the very elderly before and after the introduction of a 24/7 primary percutaneous coronary intervention service.
Shelton RJ, Crean AM, Somers K, Priestley C, Hague C, Blaxill JM, Wheatcroft SB, McLenachan JM, Greenwood JP, Blackman DJ. Shelton RJ, et al. Among authors: mclenachan jm. Am Heart J. 2010 Jun;159(6):956-63. doi: 10.1016/j.ahj.2010.02.026. Am Heart J. 2010. PMID: 20569706 Clinical Trial.
Clinical outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction according to sex and race.
Krishnamurthy A, Keeble C, Burton-Wood N, Somers K, Anderson M, Harland C, Baxter PD, McLenachan JM, Blaxill JM, Blackman DJ, Malkin CJ, Wheatcroft SB, Greenwood JP. Krishnamurthy A, et al. Among authors: mclenachan jm. Eur Heart J Acute Cardiovasc Care. 2019 Apr;8(3):264-272. doi: 10.1177/2048872617735803. Epub 2017 Oct 5. Eur Heart J Acute Cardiovasc Care. 2019. PMID: 28980483 Free article.
Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era.
Kahn MB, Cubbon RM, Mercer B, Wheatcroft AC, Gherardi G, Aziz A, Baliga V, Blaxill JM, McLenachan JM, Blackman DJ, Greenwood JP, Wheatcroft SB. Kahn MB, et al. Among authors: mclenachan jm. Diab Vasc Dis Res. 2012 Jan;9(1):3-9. doi: 10.1177/1479164111427752. Epub 2011 Nov 8. Diab Vasc Dis Res. 2012. PMID: 22067723 Free article.
Three-year clinical outcome with the Endeavor™ zotarolimus-eluting stent in primary percutaneous coronary intervention for ST elevation myocardial infarction: the Endeavor™ primary PCI study (E-PPCI).
Shelton RJ, Chitkara K, Singh R, Dorsch MF, Somers K, McLenachan JM, Blaxill JM, Wheatcroft SB, Blackman DJ, Greenwood JP. Shelton RJ, et al. Among authors: mclenachan jm. J Interv Cardiol. 2011 Dec;24(6):542-8. doi: 10.1111/j.1540-8183.2011.00674.x. Epub 2011 Aug 25. J Interv Cardiol. 2011. PMID: 21883474 Free article.
68 results